Abstract
Breast hemangioma in female infants is a rare benign lesion, prone to spontaneous regression. But when the lesion regresses there is a risk of breast atrophy if the breast bud is included in or very close to the hemangioma. A trial of corticosteroid therapy could be proposed to prevent this risk, but one must be sure that the breast bud is included in or very close to the hemangioma before treatment. We studied 4 children with breast hemangioma to evaluate the ability of MR Imaging in the diagnosis of breast bud inclusion. 0.5 Tesla axial Spin Echo T2-weighted images (TR=2000 ms; TE=120 ms) clearly depicted interface between high signal appearance of hemangioma and hypo-intensity of the breast bud: in our four patients we were able to determine whether or not the hemangioma involved the breast bud. Our preliminary study seems to demonstrate that MR imaging is a valuable imaging technique to determine which patients could be eligible for a trial of corticosteroid therapy.
References
Kolar, J, Bek V, Vrabec R (1967) Hypoplasia of the growing breast after contact X-ray therapy for cutaneous angiomas. Arch Dermatol 96: 427–430
Cohen EK, Kressel HY, Perosio T et al (1988) MR imaging of soft-tissue hemangiomas: correlation with pathologic findings. AJR 150: 1079–1081
Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69: 412–422
Lister WA (1938) The natural history of strawberry naevl. Lancet I: 1429–1434
Fost NC, Esterly NB (1968) Successful treatment of juvenile hemangiomas with prednisone. J Pediatr 72: 351–357
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miaux, Y., Lemarchand-Venencie, F., Cyna-Gorse, F. et al. MR imaging of breast hemangioma in female infants. Pediatr Radiol 22, 463–464 (1992). https://doi.org/10.1007/BF02013514
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02013514